Arkansas
CNS clinical trials in Arkansas
66 CNS studies are recruiting participants at sites in 12 cities across Arkansas as of November 16, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Arkansas city with a recruiting study
By research area: Schizophrenia (20), Depression (19), Epilepsy (6), Migraine (6), Parkinson's Disease (6), Bipolar Disorder (5), ADHD (4).
Little Rock (52), Bentonville (11), Bryant (9), Rogers (7), Fayetteville (1), Fort Smith (1), Glenwood (1), Hot Springs (1), Jonesboro (1), Osceola (1), Texarkana (1), West Memphis (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Depression: recently updated in Arkansas
Basic details from each study's public record (the 12 most recently updated of 66). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
- Phase 2
- Ages 18 to 70
- All sexes
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Recruiting in
- Rogers
- Registry record
- NCT07226661 · updated
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Phase 3
- Ages 18 to 74
- All sexes
- Sponsor
- Definium Therapeutics US, Inc.
- Recruiting in
- Little Rock
- Registry record
- NCT07592689 · updated
E-Mindfulness Approaches for Living After Breast Cancer
- Phase 3
- Ages 18 to 50
- All sexes
- Sponsor
- NRG Oncology
- Recruiting in
- Fort Smith · Jonesboro · Little Rock
- Registry record
- NCT06748222 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Arkansas on ClinicalTrials.gov.
Schizophrenia: recently updated in Arkansas
A Study to Evaluate the Effect of KarXT on Urological Safety
- Phase 4
- Ages 18 to 65
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Recruiting in
- Little Rock
- Registry record
- NCT07221877 · updated
A Study to Assess the Safety, Tolerability and Pharmacokinetics of XEP527 in Patients With Stable Schizophrenia
- Phase 1
- Ages 18 to 65
- All sexes
- Sponsor
- Novartis Pharmaceuticals
- Recruiting in
- Bentonville
- Registry record
- NCT07908680 · updated
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Phase 3
- Ages 5 to 17
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Recruiting in
- Little Rock
- Registry record
- NCT06229210 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Arkansas on ClinicalTrials.gov.
Bipolar disorder: recently updated in Arkansas
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Recruiting in
- Little Rock · Rogers
- Registry record
- NCT06951711 · updated
Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in Arkansas on ClinicalTrials.gov.
ADHD: recently updated in Arkansas
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Phase 3
- Ages 6 to 11
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Recruiting in
- Little Rock
- Registry record
- NCT07717879 · updated
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Recruiting in
- Little Rock
- Registry record
- NCT07717892 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Arkansas on ClinicalTrials.gov.
Parkinson's disease: recently updated in Arkansas
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- AstraZeneca
- Recruiting in
- Little Rock
- Registry record
- NCT06989112 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Arkansas on ClinicalTrials.gov.
Epilepsy: recently updated in Arkansas
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Rapport Therapeutics Inc.
- Recruiting in
- Bentonville
- Registry record
- NCT07594119 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Arkansas on ClinicalTrials.gov.
Migraine: recently updated in Arkansas
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Recruiting in
- Little Rock
- Registry record
- NCT07816367 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Arkansas on ClinicalTrials.gov.
Ask about studies in Arkansas
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections